ClinVar Miner

Submissions for variant NM_017780.4(CHD7):c.2097-1G>C

dbSNP: rs1060503182
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000468880 SCV000552227 pathogenic CHARGE association 2016-11-08 criteria provided, single submitter clinical testing In summary, donor and acceptor splice site variants are typically loss-of-function (PMID: 16199547), and loss-of-function variants in CHD7 are known to be pathogenic (PMID: 16400610, 22461308). As a result, this variant has been classified as Pathogenic. A different variant affecting this nucleotide has been reported de novo in a patient affected with CHARGE syndrome (PMID: 16400610), indicating that this nucleotide is crucial for normal RNA splicing. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a CHD7-related disease. This sequence change affects an acceptor splice site in intron 3 of the CHD7 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.